Spine BioPharma Initiating U.S. Phase 3 Clinical Study
Spine BioPharma, Inc., a company committed to developing non-opiate, non-surgical therapies for the treatment of chronic low back pain (CLBP) …
Spine BioPharma, Inc., a company committed to developing non-opiate, non-surgical therapies for the treatment of chronic low back pain (CLBP) …
PharmAbcine Inc., a clinical-stage biotech company focusing on the development of next-generation antibody therapeutics, announced today that Dr. Jin-San Yoo, …
Planet Fitness, Inc. (NYSE: PLNT) (the “Company”), today announced that the Company is participating in an upcoming investor conference. Cowen’s …
DetectedX announced today that it will launch its Radiology Online Learning Platform to radiologists in the United States at the …
Regulus Therapeutics Inc., a biopharmaceutical company focused on the discovery and development of innovative medicines targeting microRNAs, today announced that …
SALT LAKE CITY, May 11, 2022 /PRNewswire/ — Health Catalyst, Inc. (“Health Catalyst,” Nasdaq: HCAT), a leading provider of data …
Plant-based ingredient manufacturer KeyLeaf Life Sciences announced today its facility in Saskatoon, Canada has resumed processing of plant-derived food ingredients …
Myeloid Therapeutics, Inc. a clinical stage mRNA-immunotherapy company developing novel therapies for cancer and autoimmune diseases, today announced the first …
Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes …
FOR CANADIAN AUDIENCES ONLY Toronto-based Pentavere will collaborate with Takeda Canada and receive dedicated funding for new proof-of-concept AI project …